Baird Medical Investment Holdings (BDMD) Notes Payables (2023 - 2025)

Baird Medical Investment Holdings' Notes Payables history runs 3 years deep, the most recent figure standing at $10.4 million for Q4 2025.

• In Q4 2025, Notes Payables fell 35.47% year-over-year to $10.4 million; the TTM figure through Dec 2025 stood at $10.4 million (down 35.47% YoY), while the FY2025 annual figure was $10.4 million, down 35.47% from the prior year.
• Notes Payables was $10.4 million for Q4 2025 at Baird Medical Investment Holdings, down from $14.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $16.2 million in Q4 2024 to a low of $8.2 million in Q4 2023.
• Historically, Notes Payables has averaged $12.2 million across 3 years, with a median of $12.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Notes Payables surged 97.96% in 2024, then slumped 35.47% in 2025.
• A 3-year view of Notes Payables shows it stood at $8.2 million in 2023, then soared by 97.96% to $16.2 million in 2024, then plunged by 35.47% to $10.4 million in 2025.
• The last three Notes Payables figures came in at $10.4 million (Q4 2025), $14.0 million (Q2 2025), and $16.2 million (Q4 2024), per Business Quant data.